isabelobrien, Author at European Medical Journal - Page 27 of 65

Handshake on a green background

Lilly gains EU backing for drug to treat Crohn’s disease

The drug has received a nod from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

contract

Dr Dietmar Berger appointed as Gilead’s next Chief Medical Officer

Dr Dietmar Berger is set to join Gilead Sciences as Chief Medical Officer on 2 January 2025 – succeeding Dr Merdad Parsey.

Researchers

UK improves global clinical trial ranking, but hurdles remain

The UK is regaining its position as a global hub for industry clinical trials, according to the ABPI, but challenges remain in the space.

Dr Cecilia Caetano, Bayer

Bayer’s Dr Cecilia Caetano on making space for menopause

Find out how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Women’s Health, Bayer.

GSK drug shows promise in multiple myeloma

A trial has shown that belantamab mafodotin can reduce the risk of death by 42% in patients with relapsed or refractory multiple myeloma.

Coin stacks

Amgen expands biomanufacturing footprint in North Carolina

Amgen is investing $1bn to build a second drug substance manufacturing facility in Holly Springs, North Carolina – increasing the company’s total planned investment in the region to more than $1.5bn.

white house on blue background

Biden-Harris Administration expands access to sickle cell disease treatments

In a victory for people with sickle cell disease, the US government has announced a major step towards improving access to treatment.

Ed Smith

Onc Now: Episode 6: Revolutionising Paediatric Radiation Oncology – Part 1

Join Ed Smith, Professor at the University of Manchester, UK, to discuss the revolutionary potential of proton beam therapy and radiation oncology.

The word spotlight on a blue background

Spotlight: November 2024

Catch up on all the biggest pharma news to hit the industry last month, with stories spanning the US election, new breakthroughs and more.

ABPI calls for MHRA reform to drive UK life sciences growth

As the MHRA begins a new chapter, the ABPI has published a report outlining the importance of regulatory excellence in the UK.